History
Ultrahuman was founded by Mohit Kumar and Vatsal Singhal in 2019. [2]
Mohit Kumar, post his stint at Zomato, took a break to study martial arts at Tiger Muay Thai in Thailand. He initially observed athletes using biomarker data across streams such as glucose, HRV, blood markers etc and started designing a platform that the athletes could use to see all the data in one place. In January 2021, Ultrahuman launched its app at CES [3] in Los Angeles and Won the 'Best of CES award'. In June 2021, it launched a continuous glucose monitor called Ultrahuman M1 (formerly known as Ultrahuman Cyborg). [4]
In April 2022, Ultrahuman acquired LazyCo - a wearables IOT company. [5] LazyCo built hardware products like an AI-powered smart ring designed to predict and automate daily tasks. [6] [7] [8]
In June 2023, Ultrahuman won the Red Dot award at Berlin for its flagship Ultrahuman Ring Air. Ultrahuman has also raised 3 rounds of investments in the year 2020, 2022 and 2024 totalling up to $65 million. Ultrahuman claims to be EBITDA profitable and has declared its IPO plans for 2026.
2024–2025 developments
In December 2024 the company announced the Cycle & Ovulation PowerPlug, an optional module for Ring Air that uses biomarker data to estimate fertile windows. [9]
In August 2025 Ultrahuman acquired medical device company viO HealthTech, developer of the OvuCore vaginal temperature sensor, and OvuSense fertility algorithm. The acquisition led to the launch of Cycle & Ovulation Pro, a paid version of the cycle tracking module. TechCrunch reported that the acquisition provided access to ovulation‑tracking data and allowed the company to offer more advanced cycle predictions by porting the OvuSense algorithm to the Ultrahuman Ring AIR. [10]
In July 2025, Ultrahuman launched Blood Vision, a service that offers blood testing for more than 100 biomarkers and integrates results with data from its wearables. Forbes and HLTH reported that the service initially rolled out across 48 US states. [11] [12] In June 2025 the company introduced Ultrahuman Home, a device that monitors indoor air quality, temperature, humidity, noise and light. [13]
Research and patents
In March 2024, Ultrahuman conducted a multi-armed observational study [14] which included 105 non-diabetic and pre-diabetic individuals. It aimed to show metabolic health as a continuous spectrum between non-diabetic and diabetic individuals. The clinical trial showed a correlation between its health score, 'Metabolic score', and inflammation in the body. The trial also included blood markers and gut-microbiome index markers.
The research was published in Nature Scientific Reports . [14]
Funding
Ultrahuman has raised $65 million across three rounds of investments.
Ultrahuman raised $7.5 mn in Seed round from Nexus Venture partners and Blume ventures. [15]
In their Series A round, [16] Ultrahuman raised $17.5M in funding from Alpha Wave Incubation (AWI), [17] [18] Steadview Capital, Nexus Venture Partners, Blume Ventures and iSeed fund.
In March 2024, Ultrahuman closed a US$35 million Series B funding round, comprising US$25 million in equity and the remainder in debt. [19] The round was co‑led by existing investors Blume Ventures, Steadview Capital and Nexus Venture Partners, with participation from Alpha Wave Global and Zomato founder Deepinder Goyal. [19] Ultrahuman said it would use the proceeds to increase manufacturing capacity and fund health‑tracking research. [20] TechCrunch reported that the company, which had already achieved profitability, planned to accelerate growth through the funding and aimed to achieve US$100 million in annualized revenue run rate by the end of 2024. [21]
This page is based on this
Wikipedia article Text is available under the
CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
